Nagi Bioscience

Nagi Bioscience SA is a Swiss high-tech company founded in 2019, emerging from the Ecole Polytechnique Fédérale de Lausanne (EPFL). Based in Saint-Sulpice, Switzerland, Nagi specializes in innovative alternatives to animal testing through its Organism-on-Chip technology. The company focuses on automated biological testing solutions that allow in vivo testing at the in vitro scale using small organisms like *C. elegans*. With over 15 years of expertise in aging biology and a multidisciplinary team, Nagi aims to provide tools for faster and ethical discoveries in various fields.

The core product, SydLab™ One, is a fully automated Organism-on-Chip platform designed for standardized testing. It features automated workflows for lifespan and healthspan measurements, offering high-precision screenings that reduce costs and ethical concerns. Nagi also operates as a Contract Research Organization (CRO), providing custom experiment design, execution, and data analysis for drug discovery and nutraceutical validation. The company serves multiple sectors, including biopharma, biotech, academia, and cosmetics, emphasizing healthy aging and longevity.